Skip to main content
NIH funding notice RFA-CA-19-007

The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required)

Closed on May 22, 2019.

Posted
January 10, 2019
Close date
May 22, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $43,604,753 in first-year total cost, median $5,721,719.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RPRB-N (J1)]8

Most frequent institutions

  1. BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
  2. DANA-FARBER CANCER INST1
  3. JOHNS HOPKINS UNIVERSITY1
  4. OHIO STATE UNIVERSITY1
  5. UNIVERSITY HEALTH NETWORK1
Competing awards under RFA-CA-19-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020VICKtOrY Early Clinical Trials Consortium2UM1CA186689-06LORUSSO, PATRICIA M.YALE UNIVERSITY, CT$7,379,439ZCA1
2020Dana‐Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)2UM1CA186709-06FLAHERTY, KEITH TKUFE, DONALD W.SHAPIRO, GEOFFREY IDANA-FARBER CANCER INST, MA$6,942,412ZCA1
2020North American Star Consortium2UM1CA186644-06BEDARD, PHILIPPECOURTNEY, KEVIN DGRANT, STEVENLANCET, JEFFREYMAHALINGAM, DEVALINGAMSIU, LILLIAN LUNIVERSITY HEALTH NETWORK, ON$5,963,609ZCA1
2020The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies2UM1CA186691-06CARDUCCI, MICHAEL AGENTZLER, RYANLIU, GLENNMESSERSMITH, WELLS A.RUDEK, MICHELLE AJOHNS HOPKINS UNIVERSITY, MD$5,745,990ZCA1
2020Texas EXperimental Cancer Therapeutics Network - TEX CTN2UM1CA186688-06ECKHARDT, S. GAILKLIMBERG, VICKI SUZANNEMERIC-BERNSTAM, FUNDASARANTOPOULOS, JOHNYAO, JAMES CUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$5,697,447ZCA1
2020Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN2UM1CA186717-06COLEVAS, A. DIMITRIOSLARA, PRIMO N.LENZ, HEINZ JOSEFVILLALONA, MIGUEL ABECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$5,651,467ZCA1
2020The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network2UM1CA186712-06ARNOLD, SUSANNE MCARSON, WILLIAM E.GARRIDO-LAGUNA, IGNACIOOHIO STATE UNIVERSITY, OH$5,479,018ZCA1
2020NCI ETCTN Pittsburgh Cancer Consortium (PCC)2UM1CA186690-06BEUMER, JAN HENDRIKLUKE, JASON JOHNVILLARUZ, LIZA COSCAUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$745,371ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.